Skip to main content
Robert Gerszten, MD, Cardiology, Boston, MA, Beth Israel Deaconess Medical Center

RobertEGersztenMD

Cardiology Boston, MA

Cardiovascular Disease Genetics

Chief of Cardiovascular Medicine, Beth Israel Deaconess Medical Center Herman Dana Professor of Medicine, Harvard Medical School

Dr. Gerszten is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gerszten's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Cardiovascular Disease, 1996
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1989 - 1993
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1989

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1991 - Present
  • MA State Medical License
    MA State Medical License 1993 - 2024
  • PA State Medical License
    PA State Medical License 1990 - 1991
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2006

Publications & Presentations

PubMed

Press Mentions

  • Scientists Find Predictors of Heart Disease Among Black Americans That Are Shared Across Ethnicities
    Scientists Find Predictors of Heart Disease Among Black Americans That Are Shared Across EthnicitiesJanuary 21st, 2022
  • New Research Suggests a Blood Test Can Help Direct Our Workouts
    New Research Suggests a Blood Test Can Help Direct Our WorkoutsJuly 15th, 2021
  • A Blood Test Could Reveal Which Type of Exercise Is Most Effective for You
    A Blood Test Could Reveal Which Type of Exercise Is Most Effective for YouJune 12th, 2021
  • Join now to see all

Grant Support

  • Metabolomic Biomarkers Of Early Myocardial InjuryNational Heart, Lung, And Blood Institute2010–2012
  • Clinical Characterization Of The Apol1-Associated PhenotypeNational Institute Of Diabetes And Digestive And Kidney Diseases2011
  • Integrating Lipid Genotyes And Phenotypes In IPS Derived Hepatocytes/AdipocytesNational Heart, Lung, And Blood Institute2011
  • Discovery &Application Of Proteomics-Based Biomarkers Of Early Myocardial InjuryNational Heart, Lung, And Blood Institute2009–2011
  • Metabolomic Predictors Of Insulin Resistance And DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
  • Role Of ILK In Leukocyte RecruitmentNational Heart, Lung, And Blood Institute2005–2009
  • Novel Markers: Pathways, Prognosis, &PharmacoproteomicsNational Heart, Lung, And Blood Institute2005–2008
  • Patients Undergoing Alcohol Septal Ablation For Hypertrophic CardiomyopathyNational Heart, Lung, And Blood Institute2005
  • Biomarkers In "Normal" Myocardial Ischemia And InfarctionNational Heart, Lung, And Blood Institute2005
  • Clinical Evaluation Of Novel Markers Of MINational Heart, Lung, And Blood Institute2002–2005
  • Chemokine Signal In Monocyte RecruitmentNational Heart, Lung, And Blood Institute2001–2003
  • Chemokine Signaling In Monocyte Recruitment In VivoNational Heart, Lung, And Blood Institute2001–2002
  • Molecular Signals In Monocyte RecruitmentNational Heart, Lung, And Blood Institute1996–2000

Hospital Affiliations